MedPath
HSA Approval

PRIMZOLE TABLETS

SIN00901P

PRIMZOLE TABLETS

PRIMZOLE TABLETS

May 9, 1988

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

J01EE01

sulfamethoxazole and trimethoprim

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

SULPHAMETHOXAZOLE

400 mg

Sulfamethoxazole

TRIMETHOPRIM

80 mg

Trimethoprim

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PRIMZOLE TABLETS - HSA Approval | MedPath